azalanstat has been researched along with 4-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-butanone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acquaviva, R; Barbagallo, I; Di Giacomo, C; Modica, MN; Pittalà, V; Romeo, G; Salerno, L; Siracusa, MA; Sorrenti, V; Tibullo, D | 1 |
| Amata, E; Barbagallo, I; Floresta, G; Marrazzo, A; Pittalà, V; Prezzavento, O; Rescifina, A; Romeo, G; Salerno, L; Sorrenti, V | 1 |
2 other study(ies) available for azalanstat and 4-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-butanone
| Article | Year |
|---|---|
Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.
Topics: Animals; Antineoplastic Agents; Brain; Cell Cycle Checkpoints; Cell Line; Cell Survival; Enzyme Inhibitors; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Imidazoles; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Spleen; Triazoles | 2013 |
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors.
Topics: Animals; Binding Sites; Heme Oxygenase-1; Hydrophobic and Hydrophilic Interactions; Imidazoles; Inhibitory Concentration 50; Models, Molecular; Rats; Structure-Activity Relationship | 2018 |